Study for effects of rosuvastatin on glucose and lipid metabolism in patients with type 2 diabeteic patients

Not Applicable

• Conditions: Type 2 diabeteic patients with dyslipidemia

• Registration Number: JPRN-UMIN000009156
• Lead Sponsor: Yokohama City Unuversity School of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-10-20
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

1)HbA1c>=9.4 %(NGSP) 2)Patients with type 1 diabetes,Severe ketosis,Diabetic coma 3)Patients with hyperkalemia 4)Patients with severe liver failure or renal failure 5)Patient with severe infection, perioperative,severe trauma 6)Pregnant and possibly pregnant women 7)Patients having liver failure,and getting a rash for statins 8)Other patients determined to be inappropriate by physician

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes of HbA1c, nonHDL-C, T-C, LDL-C, HDL-C from the baseline to 6 months later.

Secondary Outcome Measures

Name	Time	Method
Change of C-peptide, sd-LDL, MDA-LDL, Apo-B, Apo-AI, Cystatin C,high-molecular-weight adoponectin, TNF-alpha from the baseline to 6 months later.